(Hypertension. 1995;26:401-405.)
© 1995 American Heart Association, Inc.
Articles |
From the First Department of Internal Medicine, Osaka City (Japan) University Medical School.
Correspondence to Miwako Ikeda, MD, Division of Hypertension and Atherosclerosis, First Department of Internal Medicine, Osaka City University Medical School, 1-5-7 Asahi-machi, Abeno-ku, Osaka 545, Japan.
Abstract Vascular endothelial cell migration is proposed to be an important process in the initiation and progression of atherosclerosis. We designed the present study to examine the effects of atrial and brain natriuretic peptides on fetal calf serumstimulated migration of cultured rat aortic endothelial cells using Boyden's chamber method. Fetal calf serum clearly stimulated migration in a concentration- and time-dependent manner. Rat atrial natriuretic peptide-(1-28) and rat brain natriuretic peptide-45, which are the major circulating forms of atrial and brain natriuretic peptides in rats, inhibited fetal calf serumstimulated migration in a concentration-dependent manner between 10-10 and 10-6 mol/L. Such inhibition by these natriuretic peptides was paralleled by an increase in the cellular level of cGMP. The addition of a cGMP analogue 8-bromo-cGMP, significantly inhibited fetal calf serumstimulated migration in a concentration-dependent manner between 10-7 and 10-3 mol/L. Rat atrial natriuretic peptide-(5-25) was much less effective than atrial natriuretic peptide-(1-28) or rat brain natriuretic peptide-45 with respect to inhibiting migration and increasing cGMP levels. These results indicate that atrial and brain natriuretic peptides inhibit fetal calf serumstimulated vascular endothelial cell migration, probably through a cGMP-dependent process.
Key Words: natriuretic peptides vascular endothelium cell movement rats
This article has been cited by other articles:
![]() |
H. Kook, H. Itoh, B. S. Choi, N. Sawada, K. Doi, T. J. Hwang, K. K. Kim, H. Arai, Y. H. Baik, and K. Nakao Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1388 - H1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamahara, H. Itoh, T.-H. Chun, Y. Ogawa, J. Yamashita, N. Sawada, Y. Fukunaga, M. Sone, T. Yurugi-Kobayashi, K. Miyashita, et al. Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration PNAS, March 18, 2003; 100(6): 3404 - 3409. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ueno, A. Haruno, N. Morisaki, M. Furuya, K. Kangawa, A. Takeshita, and Y. Saito Local Expression of C-Type Natriuretic Peptide Markedly Suppresses Neointimal Formation in Rat Injured Arteries Through an Autocrine/Paracrine Loop Circulation, October 7, 1997; 96(7): 2272 - 2279. [Abstract] [Full Text] |
||||
![]() |
A. Smolenski, W. Poller, U. Walter, and S. M. Lohmann Regulation of Human Endothelial Cell Focal Adhesion Sites and Migration by cGMP-dependent Protein Kinase I J. Biol. Chem., August 11, 2000; 275(33): 25723 - 25732. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |